HOXA9 and HOXA10 genes were associated with a shorter survival in pediatric high-grade glioma patient samples [31], while elevated HOXA9 and HOXA10 gene methylation was associated with an increased survival probability [32]. The gene discussed is HOXA9; the disease is malignant glioma.